Resources
A clinical cytogenetics lab performs an in vitro prenatal diagnostic procedure comparing cell-free fetal DNA (cffDNA) testing via maternal plasma shotgun sequencing with conventional G-banded karyotyping from amniocentesis. In maternal plasma at 11 weeks of gestation, total cell-free DNA concentration is , with a fetal fraction (FF) of (). For an autosomal trisomy (e.g., Trisomy 21), let the expected representation of chromosome 21 reads relative to total genomic reads be modeled as . Given that the baseline euploid chromosome 21 read fraction is , calculate: (a) the expected chromosome 21 read fraction in this maternal plasma sample, and (b) contrast the non-invasive nature of cffDNA with its key diagnostic limitation relative to amniocentesis karyotyping in distinguishing full trisomy from balanced Robertsonian translocations or placental mosaicism.
Answer and steps
Final answer
(a) ; (b) cffDNA derives primarily from apoptotic placental trophoblasts rather than fetal tissues directly (leading to false positives from confined placental mosaicism) and cannot determine structural chromosomal architecture or balanced translocations, requiring amniocentesis karyotype confirmation.
Steps
Part (a): Calculating the Expected Read Fraction ()
-
Understand the quantitative effect of trisomy on cell-free DNA (cfDNA): Maternal plasma contains a mixture of maternal cfDNA (fraction ) and fetal cfDNA (fraction ).
- In a normal euploid fetus, both maternal and fetal genomes are disomic ( copies of chromosome 21).
- In a fetus with trisomy 21, the fetal contribution contains copies of chromosome 21 instead of , an increase of (a increase) in the fetal compartment.
- Therefore, the relative genomic representation increases by , yielding the model:
-
Substitute the given values into the formula:
- Baseline euploid fraction:
- Fetal fraction:
(Note: The total cfDNA concentration of confirms sufficient yield for sequencing, but the proportional read representation depends entirely on the fetal fraction .)
Part (b): Diagnostic Limitations of cffDNA vs. Karyotyping
-
Non-invasive nature vs. tissue origin: cffDNA testing (non-invasive prenatal screening, NIPS) requires only a peripheral maternal blood draw, posing no risk of miscarriage. However, "fetal" cfDNA is actually derived from the apoptosis of placental syncytiotrophoblasts, not the fetus itself. Because of this:
- Confined Placental Mosaicism (CPM): Chromosomal abnormalities confined solely to the placenta can produce false-positive screening results, while normal placental cells paired with an affected fetus can yield false-negative results.
-
Structural resolution vs. conventional karyotyping:
- Counting-based shotgun sequencing quantifies total read depth per chromosome but does not visualize individual chromosome architecture. It cannot identify the physical arrangement of chromosomes, such as distinguishing free trisomy 21 from an unbalanced or balanced Robertsonian translocation (e.g., ).
- In contrast, invasive diagnostic testing via amniocentesis harvests intact, viable fetal amniocytes. G-banded karyotyping directly visualizes structural arrangements, breaks, and mosaic levels across cultured cell colonies, serving as the definitive diagnostic standard.
Typical errors
01 The student forgets that the extra chromosome in trisomy adds half of the fetal contribution (f/2) and instead adds the full fetal fraction (f), yielding an overestimated read fraction.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You omitted the factor of applied to the fetal fraction . In trisomy 21, the fetus has 3 copies instead of 2, representing a proportional increase of (a increase) within the fetal compartment alone, so the excess signal contributed by the fetus is .
- Step 2
cffDNA is non-invasive because it only requires a maternal blood draw, avoiding amniocentesis procedural risks. However, cffDNA is derived from placental trophoblasts and measures read counts rather than structural arrangements, so it cannot detect balanced Robertsonian translocations or rule out confined placental mosaicism.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly explained why maternal plasma testing is non-invasive compared to amniocentesis.
You clearly identified that cffDNA originates from placental trophoblasts, leading to limitations like confined placental mosaicism.
You recognized that read-counting approaches cannot resolve physical chromosome structures or balanced Robertsonian translocations.
THE ERROR
Where Your ACEpath Teacher Spotted the Mistakeno
WHY IT HAPPENED
ACEpath Teacher's DiagnosisYou treated the fetal fraction as adding an entirely redundant disomic genome equivalent () rather than accounting for the single extra chromosome copy out of two normal homologues ().
REASONING PATH
Your ACEpath teacher’s suggested approach- Aneuploidy Fractional Increase
For a standard disomic organism, an extra chromosome adds relative to the normal diploid fetal contribution, producing a net read increase of .
Always verify whether the fetal fraction is scaled by the fractional change in copy number: , where for trisomy and for monosomy.
CORRECTED PATH
ACEpath Teacher's DemonstrationApply the given trisomy read representation model: .
Substitute the baseline fraction and fetal fraction : .
Multiply to find the expected read fraction: .
(a) ; (b) cffDNA is non-invasive via maternal venipuncture, but because it derives from placental trophoblasts and quantifies read depth without structural karyotype visualization, it cannot rule out confined placental mosaicism or detect balanced Robertsonian translocations.
02 The student misinterprets the 8.00% fetal fraction as 0.800 rather than 0.0800, leading to an artificially high read fraction.
Sample Student Work
Reviewed by ACEpath TeacherStep-by-Step Review
Walk Through It with Your Teacher- Step 1Correct
You correctly set up the mathematical model , but you converted to instead of . A fetal fraction of represents , which inflated your multiplier from to .
- Step 2
cffDNA is non-invasive because it samples circulating cell-free DNA from maternal venous blood without needle puncture of the amniotic sac. A major diagnostic limitation is that cffDNA reflects placental apoptosis and only counts genomic dosage, meaning it cannot visualize chromosomal structural rearrangements like balanced translocations or confirm true fetal lineage versus placental mosaicism.
WHAT YOU DID WELL
Compliments from Your TeacherYou correctly identified and applied the mathematical formula for autosomal trisomy read fraction.
You clearly explained why cffDNA sampling is non-invasive compared to amniocentesis.
You thoroughly identified the clinical and biological limitations of cffDNA, including placental mosaicism and structural rearrangement detection.
THE ERROR
Where Your ACEpath Teacher Spotted the MistakeYou wrote as instead of , shifting the decimal point one place to the right.
WHY IT HAPPENED
ACEpath Teacher's DiagnosisConflating single-digit percentages (e.g., ) with tenths (e.g., ) when converting percentages to decimals in clinical quantitative genetics formulas.
REASONING PATH
Your ACEpath teacher’s suggested approach- Percentage-to-Decimal Conversion Check
To convert a percentage to a decimal, divide by (move the decimal point two places to the left): .
Always verify biological plausibility: early pregnancy fetal fractions are typically (), never ().
CORRECTED PATH
ACEpath Teacher's DemonstrationExpress the fetal fraction as a decimal: .
Calculate the trisomy dosage factor: .
Multiply by the baseline euploid read fraction: .
(a) ; (b) cffDNA derives primarily from apoptotic placental trophoblasts rather than fetal tissues directly (leading to false positives from confined placental mosaicism) and cannot determine structural chromosomal architecture or balanced translocations, requiring amniocentesis karyotype confirmation.
Lock it in
Why does fetal trisomy increase maternal plasma chromosome reads by rather than by ?
Normal disomy contributes 2 copies. A third copy adds 1 extra chromosome for every 2 expected, a increase () of the fetal compartment .
Similar question
A maternal plasma sample at 12 weeks of gestation has a fetal fraction of . If the baseline euploid read fraction for chromosome 18 is , calculate the expected read fraction in a pregnancy affected by Trisomy 18.
Answer
. Key step: Calculate the scaling factor , then multiply .
In a screening test for Monosomy 21 (loss of one copy of chromosome 21), maternal plasma sequencing yields an observed read fraction of , while the normal euploid reference is . Assuming the model , calculate the estimated fetal fraction .
Answer
(). Key step: Set up .
A non-invasive prenatal screening (NIPS) result indicates high risk for Trisomy 13, but subsequent G-banded karyotyping from amniocentesis demonstrates a normal fetal constitution. (a) Name the biological phenomenon involving placental lineage divergence that most commonly accounts for this discordant result. (b) Explain why chorionic villus sampling (CVS) could also yield a misleading result in this scenario, whereas amniocentesis provides the definitive diagnosis.
Answer
(a) Confined placental mosaicism (CPM). (b) CVS samples chorionic villi derived from the same outer trophoblast/extraembryonic lineage as cffDNA, thus replicating the abnormal placental cell line. In contrast, amniocentesis samples amniocytes derived from the inner cell mass/epiblast, directly reflecting true fetal chromosomal constitution.